News | January 16, 2007

Senate Bill Aims to Stop Generic Drug Pacts

Jan. 17, 2007 - The chairman of the Senate Judiciary Committee said on Wednesday he will introduce legislation to prevent drugmakers from striking deals that restrict the introduction of cheaper generic drugs.

The bill planned by Sen. Patrick Leahy, a Vermont Democrat, targets an increasingly common tactic used by brand-name drug makers — legal settlements that involve payments to generic rivals to restrict the sale of generic alternatives.

Leahy said the bill is supported by several other senators, including Republican Charles Grassley of Iowa.

"Congress never intended brand-name drug companies to be able to pay off generic companies not to produce generic medicines," Leahy said at a Judiciary Committee hearing. "That would be a shame, harmful to consumers and a crime."

During the hearing, a government antitrust official warned that legal settlements between major drugmakers and their generic rivals were a fast-growing problem that is stunting competition in the market for prescription drugs.

Generic drugs are typically cheaper for consumers to buy than brand name drugs, and the Federal Trade Commission has filed several lawsuits in recent years challenging the settlements as anti-competitive.

In some cases, the FTC contended the settlements are a way for drugmakers to pay generics to stay out of the market.

The industry has been emboldened to forge such agreements by recent court rulings that have derailed several of the FTC's legal challenges.

In one key decision in 2005, an appeals court in Atlanta overturned an FTC ruling that said Schering-Plough Corp. had illegally kept cheaper versions of its blood pressure drug K-Dur off the market through patent settlements with generic competitors. The U.S. Supreme Court turned down a petition to review the case last year.

Under federal law, drugmakers are allowed to seek FDA approval for generic versions of brand-name drugs before a drug's patent expires. They must certify that the patent is invalid or will not be infringed by the new generic version.

Related Content

MDISS Launches 'WHISTL' Network of Medical Device Security Testing Labs
News | Cybersecurity | August 23, 2017
The Medical Device Innovation, Safety and Security Consortium (MDISS) recently launched the first of more than a dozen...
Sponsored Content | Videos | Information Technology | August 22, 2017
Melissa Martin, MS, president of the American Association of Physicists in Medicine (AAPM), discusses her vision of t
HHS Unveils Improved Web Tool to Highlight Recent Health Information Breaches
News | Cybersecurity | August 21, 2017
The U.S. Department of Health and Human Services (HHS), Office for Civil Rights (OCR) recently launched a revised web...
Enterprise Imaging Growing Its Share of Imaging IT Market
Feature | Enterprise Imaging | August 18, 2017
August 16, 2017 — A new imaging information technology (IT) market report from Signify Research suggests...
MaineHealth Selects eUnity Platform for Clinical and Diagnostic Viewing
News | Enterprise Imaging | August 17, 2017
August 17, 2017 — Client Outlook recently announced that MaineHealth has selected eUnity as its...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
ScImage Awarded U.S. Government DIN-PACS IV Contract
News | PACS | August 16, 2017
ScImage Inc. was recently awarded a new DIN-PACS IV (Digital Imaging Network/Picture Archiving and Communications...
Neighbors Emergency Center Selects Novarad PACS/RIS
News | PACS | August 15, 2017
August 15, 2017 — Novarad Corp.
Sponsored Content | Whitepapers | Enterprise Imaging | August 11, 2017
All around the world, regulatory requirements and market forces are driving a growing demand for higher-quality, more-...
RSNA Announces Pediatric Bone Age Machine Learning Challenge
News | Artificial Intelligence | August 10, 2017
August 10, 2017 — The Radiological Society of North America (RSNA) is organizing a challenge intended to show the app
Overlay Init